Association Between Feritine Levels and Severity of COVID19 In RSUP Dr. M. Djamil Padang

Elsa Purnama Sari, Irvan Medison, Russilawati Russilawati

Abstract


Background: Ferritin is one of the inflammatory markers used as a predictor for severity of COVID-19. Early assessment of severity is expected to be a priority in disease management. This study aims to determine the association between ferritin levels and the severity of confirmed COVID-19 patients at RSUP dr. M. Djamil Padang.

 

Methods: This study is a retrospective cohort study on confirmed COVID-19 patients from January to May 2021. Chi-square analysis was calculated to assess the association between ferritin levels and clinical grade, the severity of the chest X-ray and the level of need for oxygen therapy. To assess the risk opportunities for ferritin levels based on each dependent variable, an association analysis was performed by calculating the Odds Ratio..

Results: Characteristics of the patients were mostly female (54.25%), aged more than 50 years (59,00%), clinical grade above category 4 (54,75%), required oxygen therapy (74,75%), the severity of chest X-ray was mild (75.50%), ferritin level < 500 ng/ml (52.75%) and had no comorbidities (51.25%). This study found that ferritin levels correlated with clinical grade, severity of chest X-ray, and level of need for oxygen therapy with HFNC and ventilator (p<0.001). Ferritin levels > 1000 ng/mL have a risk opportunity for clinical grade category 7 OR 8.28 (95% CI 2.69-25.41), severe chest X-ray severity OR 5.52 (95% CI 2.55- 11.97) and need for oxygen therapy with HFNC and ventilator, OR 4.76 (2.70-8.39) vs OR 7.69 (3.97-14.92)

Conclusion: High ferritin levels significantly increase the risk of a severe clinical severity, severe chest X-ray and the level of need for oxygen therapy using HFNC and a ventilator in COVID-19 patients.

Keywords: COVID-19, ferritin levels, severity


Keywords


COVID-19, ferritin levels, severity

References


Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg Heal - West Pacific. 2021;9:108–14. internet. Jakarta; 2021.

Tang D, Comish P, Kang R. The hallmarks of COVID-19 disease. PLoS Pathog. 2020;16(5):1–24.

Bozkurt FT, Tercan M, Patmano G, Bingol Tanrıverdi T, Demir HA, Yurekli UF. Can Ferritin Levels Predict the Severity of Illness in Patients With COVID-19? Cureus. 2021;13(1):1–8.

Cheng L, Li H, Li L, Liu C, Yan S, Chen H, et al. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal. 2020;34(10):1–18.

Riveiro-Barciela M, Labrador-Horrillo M, Camps-Relats L, Gonzalez-Sans D, Ventura-Cots M, Terrones-Peinador M, et al. Simple predictive models identify patients with COVID-19 pneumonia and poor prognosis. PLoS One. 2020;15(1):1–14.

Perrotta F, Corbi G, Mazzeo G, Boccia M, Aronne L, D’Agnano V, et al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res. 2020;32(8):1599–608.

Sensusiati AD, Amin M, Nasronudin N, Rosyid AN, Ramadhan NA, Lathifah R, et al. Age, neutrophil lymphocyte ratio, and radiographic assessment of the quantity of lung edema (RALE) score to predict in-hospital mortality in COVID-19 patients: A retrospective study. F1000Research. 2021;9(1):1–13.

Ni YN, Wang T, Liang BM, Liang ZA. The independent factors associated with oxygen therapy in COVID-19 patients under 65 years old. PLoS One. 2021;16(1 January):1–11.

Chen J, Jiang Q, Xia X, Liu K, Yu Z, Tao W, et al. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell. 2020;19(7):1–12.

Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the Treatment of Covid-19 — Final Report. N Engl J Med. 2020;383(19):1813–26.

Procopio G, Cancelliere A, Trecarichi EM, Mazzitelli M, Arrighi E, Perri G, et al. Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study. Ther Adv Respir Dis. 2020;14:1–10.

Sathi S, Tiwari R, Verma S, Garg AK, Saini VS, Singh MK, et al. Role of Chest X-Ray in Coronavirus Disease and Correlation of Radiological Features with Clinical Outcomes in Indian Patients. Can J Infect Dis Med Microbiol. 2021;2021(3):1–8.

Ghweil AA, Hassan MH, Khodeary A, Mohamed AO, Mohammed HM, Abdelazez AA, et al. Characteristics, outcomes and indicators of severity for covid-19 among sample of esna quarantine hospital’s patients, egypt: A retrospective study. Infect Drug Resist. 2020;13:2375–83.

Khedr EM, Daef E, Mohamed-Hussein A, Mostafa EF, Zein M, Hassany SM, et al. Impact of comorbidities on COVID-19 outcome. medRxiv. 2020;2(3):1–26.

Dahan S, Segal G, Katz I, Hellou T, Tietel M, Bryk G, et al. Ferritin as Marker of Severity in COVID-19 Patients: A Fatal Correlation. Isr Med Assoc J. 2020;22(1):1–7.

Gandini O, Criniti A, Ballesio L, Giglio S, Galardo G, Gianni W, et al. Serum Ferritin is an independent risk factor for Acute Respiratory Distress Syndrome in COVID-19. J Infect. 2020;81(6):979–97.

Kappert K, Jahić A, Tauber R. Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases. Biomarkers. 2020;25(8):616–25.

Perricone C, Bartoloni E, Bursi R, Cafaro G, Guidelli GM, Shoenfeld Y, et al. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol Res. 2020;68(4):213–24.

Hussein AM, Taha ZB, Gailan A, Akram K, Qasim D, Jalal R, et al. D-Dimer and Serum Ferritin as an Independent Risk Factor for Severity in COVID-19 Patients. Mater today. 2020;1(1):11–3.

Eroglu SA, Cagavi Z, Yildiz T, Karakurt Z, Interest Group O behalf of C. Can the Usage of the Chest X-Ray Scoring During Hospitalization in Patients with COVID-19 Predict the Severity of the Disease? Turkish Thorac J. 2021;22(3):190–8.

Kaleemi R, Hilal K, Arshad A, Martins RS, Nankani A, Haq TU, et al. The association of chest radiographic findings and severity scoring with clinical outcomes in patients with COVID-19 presenting to the emergency department of a tertiary care hospital in Pakistan. PLoS One. 2021;16(3):1–11.

Borghesi A, Zigliani A, Golemi S, Carapella N, Maculotti P, Farina D, et al. Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study 0f 302 patients from Italy. Int J Infect Dis. 2020;96(1):291–3.

Setiawati R, Widyoningroem A, Handarini T, Hayati F, Basja AT, Surya ARD, et al. Modified chest X-ray scoring system in evaluating severity of COVID-19 patient in dr. Soetomo general hospital Surabaya, Indonesia. Int J Gen Med. 2021;14:2407–12.

Feld J, Tremblay D, Thibaud S, Kessler A, Naymagon L. Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis. Int J Lab Hematol. 2020;42(6):773–9.

Burhan E, Susanto AD, Isbaniah F, Nasution SA, Ginanjar E, Pitoyo CW SA. Pedoman tatalaksana COVID-19 Edisi 3 Desember 2020. Pedoman Tatalaksana COVID-19. 2020. 15–18p.




DOI: https://doi.org/10.36497/jri.v42i3.244

Refbacks

  • There are currently no refbacks.




Copyright (c) 2022 Jurnal Respirologi Indonesia

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


INDEXING & PARTNER

SINTA Garuda Indonesian Scientific Journal Database (ISJD) Indonesia One Search (IOS) Crossref

ROAD-ISSN Dimensions Google Scholar 

 

Jurnal Respirologi Indonesia
pISSN: 0853-7704 - eISSN: 2620-3162
Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia
Phone: +62-21-2247-4845
Email: editor@jurnalrespirologi.org


An official publication by
the Indonesian Society of Respirology (ISR)

Creative Commons License
Creative Commons Attribution-NonCommercial 4.0 International License

Statcounter